ClinicalTrials.govpublic full text
A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL
pcnsl, primary central nervous system lymphoma, primary central nervous system lymphoma (pcnsl), methotrexate, rituximab, sintilimab, pirtobrutinib, real-world evidence, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 913144
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.